SS Innovations International (SSII) Short term Debt (2018 - 2024)
SS Innovations International's (SSII) quarterly Short term Debt came in at -$510189.0 in Q3 2024, down 202.22% year-on-year from $499118.0 in Q4 2023, and down 195.57% quarter-over-quarter from $533854.0 in Q2 2024.
SS Innovations International (SSII) Short term Debt (2018 - 2024) Analysis & Trends
SS Innovations International has disclosed Short term Debt across 7 years of filings, most recently posting -$510189.0 for Q3 2024.
- Short term Debt for Q3 2024 came in at -$510189.0, down 202.22% year-over-year; the trailing twelve-month figure through Sep 2024 was -$510189.0 (down 202.22% YoY), and the FY2023 annual result was $510189.0, up 322.06% from the prior year.
- Short term Debt came in at -$510189.0 for Q3 2024 at SS Innovations International, down from $533854.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $533854.0 in Q2 2024 to a low of -$510189.0 in Q3 2024.
- The 5-year median for Short term Debt is $195000.0 (2020), against an average of $235216.8.
- Peak annual rise in Short term Debt reached 2471.55% in 2024, while the deepest fall reached 202.22% in 2024.
- SS Innovations International's Short term Debt stood at $195000.0 in 2020, then fell by 25.64% to $145000.0 in 2021, then slipped by 16.63% to $120880.0 in 2022, then surged by 322.06% to $510189.0 in 2023, then slumped by 200.0% to -$510189.0 in 2024.
- The last three Short term Debt figures came in at -$510189.0 (Q3 2024), $533854.0 (Q2 2024), and $521873.0 (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -510,189.00 |
| Jun 30, 2024 | 533,854.00 |
| Mar 31, 2024 | 521,873.00 |
| Dec 31, 2023 | 510,189.00 |
| Sep 30, 2023 | 499,118.00 |
| Jun 30, 2023 | 20,760.00 |
| Dec 31, 2022 | 120,880.00 |
| Jun 30, 2022 | 145,000.00 |
| Mar 31, 2022 | 145,000.00 |
| Dec 31, 2021 | 145,000.00 |
| Sep 30, 2021 | 145,000.00 |
| Jun 30, 2021 | 195,000.00 |
| Mar 31, 2021 | 195,000.00 |
| Dec 31, 2020 | 195,000.00 |
| Sep 30, 2020 | 388,700.00 |
| Jun 30, 2020 | 380,000.00 |
| Mar 31, 2020 | 368,500.00 |
| Dec 31, 2019 | 367,500.00 |
| Sep 30, 2019 | 272,500.00 |
| Jun 30, 2019 | 122,500.00 |